By Josh White
Date: Wednesday 02 Jul 2025
(Sharecast News) - Avacta Therapeutics provided a second-quarter business update on Wednesday, reporting continued progress in its oncology pipeline and strengthening of its leadership team as it advanced its 'preCISION' drug development strategy.
By Josh White
Date: Friday 06 Jun 2025
(Sharecast News) - Avacta Group reported a reduced pre-tax loss of £28.98m from continuing operations in 2024 on Friday, down from £31.13m the year prior, as it accelerated its transformation into a pure-play oncology biotech.
By Benjamin Chiou
Date: Tuesday 27 May 2025
(Sharecast News) - Life sciences company Avacta Therapeutics has announced that it has had to delay the release of its annual results by a week.
Currency | UK Pounds |
Share Price | 30.50p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 82.50 |
52 Week Low | 27.50 |
Volume | 2,049,668 |
Shares Issued | 386.87m |
Market Cap | £117.99m |
RiskGrade | 461 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 2 |
Buy | 0 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 3 |
No dividends found |
Time | Volume / Share Price |
17:05 | 43,000 @ 30.50p |
16:25 | 4,200 @ 30.01p |
16:22 | 16,154 @ 30.00p |
16:22 | 330 @ 30.00p |
16:21 | 10,312 @ 30.11p |
You are here: research